Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × cemiplimab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 20 Skin Neoplasms 7 Melanoma 7 Lung Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 4 Neoplasm Metastasis 4 Carcinoma, Squamous Cell 3 Carcinoma, Renal Cell 3 Breast Neoplasms 3 Adenocarcinoma 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Recurrence 2 Neoplasms 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2 Glioblastoma 2 Colorectal Neoplasms 2 Carcinoma, Merkel Cell 2 Carcinoma, Large Cell 2 Carcinoma, Basal Cell 2 Carcinoma 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Solid Tumors 1 Solid Tumor 1 Sinonasal Squamous Cell Carcinoma 1 SMARCB1-Deficient Malignancies 1 Resectable Non-small Cell Lung Cancer 1 Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck 1

Interventions

Bevacizumab 24 atezolizumab 19 durvalumab 18 Specimen Handling 15 pembrolizumab 12 lenvatinib 11 Magnetic Resonance Spectroscopy 11 tremelimumab 10 Nivolumab 10 Sorafenib 8 Radiosurgery 8 Cyclophosphamide 6 camrelizumab 5 apatinib 5 Ipilimumab 5 tislelizumab 4 regorafenib 4 fludarabine 4 cabozantinib 4 X-Rays 4 Immunoglobulin G 4 sintilimab 3 gadolinium ethoxybenzyl DTPA 3 Immune Checkpoint Inhibitors 3 Ethiodized Oil 3 E-7386 3 Disulfides 3 Blood Specimen Collection 3 Biopsy 3 gadobutrol 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡